REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/16/2026
Back to search
Official data from USPTO
INFERTREAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/17/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/01/2020
Registration date
03/16/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2021
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
FOX III, LYAL L
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "INFERTREAT".
Holders and representatives
Holders
LIVZON PHARMACEUTICAL GROUP INC.
Representatives
Nicholas D. Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Hormonal preparations; hormones for medical purposes; veterinary pharmaceutical preparations for the treatment of hormonal disorder of livestock; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; depuratives for the body; sanitizing wipes; pharmaceutical preparations for the treatment of hormonal disorders; fertility enhancement preparations; estrogen preparations; hormones for medical use
Publications
History of USPTO decisions and trademark events.
26 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/17/2021
FIMP
FINAL DISPOSITION PROCESSED
06/17/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/16/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2020
PUBO
PUBLISHED FOR OPPOSITION
12/29/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/24/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2020
RFNT
REFUSAL PROCESSED BY IB
12/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/25/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/16/2020
RFRR
REFUSAL PROCESSED BY MPU
11/16/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/31/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/29/2020
CNRT
NON-FINAL ACTION WRITTEN
10/28/2020
DOCK
ASSIGNED TO EXAMINER
10/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/27/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/26/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/18/2020
Continuous trademark protection
Get notified about every new filing that threatens INFERTREAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.